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There is extensive intraspecific variation in
the behavior of naturally occurring Trypanosoma
cruzi populations. Several authors1 3 4 5 8 9 11 14 15
have suggested that the variation in T. cruzi
populations may be related to variation in the
epidemiological and clinical aspects of Chagas
disease in man. The enormous behavioral
heterogeneity of this protozoan has been shown
by both in vitro and in vivo studies1 3 5 11 and
by schizodeme3 4 20 23 and RFLP profiles14 21 27.
Variation of the parasites described in the above
reports suggests that further studies should be
carried out with clonal populations derived
from Chagas disease patients with well-defined
pathology. Examination of the T. cruzi isolates
from heart and esophageal patients and their
resulting clonal lines (each derived from a
single cell yielding a genetically homogeneous
population) will shed light on the role played
in this scenario by a particular parasite isolate
or a subpopulation thereof. This paper reports
on the behavioral characteristics of T. cruzi
isolates and their clonal lines derived from two
patients with the cardiac and the digestive
forms of this disease.
MATERIAL AND METHODS
Trypanosoma cruzi stocks and clones. In
this study we isolated T. cruzi by xenodiagnosis
from two patients with chronic Chagas disease.
The parasite stock hSLU239 was obtained from
a patient with the cardiac disease, whereas
stock mSLU142 derived from a patient with the
digestive form (megaesophagus) of the disease.
The metacyclic trypomastigotes passed in the
feces of first instar nymphs of Dipetalogaster
maximus used for xenodiagnosis were used to
inoculate Balb/c mice. One week af ter
inoculation the blood trypomastigotes were
obtained by cardiac puncture. The red cells
were lysed in 0.78% ammonium chloride and
the parasite forms were used to infect primary
cultures of fetal mouse skeletal muscle cells26.
The cell cloning experiments consisted of
infecting murine skeletal muscle cell culture in
24 well plates with a single trypomastigote9 26.
The parasite suspension in culture medium
was diluted to contain a single cell per 5µl.
This cell dilution aliquot was placed on sterile
cover slip in Petri dish and examined with an
inverted microscope. Each 5µl aliquot containing
a single parasite was transferred to a well of
the plate. One week thereafter infected host
cells in each well was observed with an
inverted microscope. In a parallel control
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populations; ii) clonal lines derived from patient samples may have different biological
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molecular markers are required for further characterization of Trypanosoma cruzi
stocks and clones derived from Chagas disease patients in order to identify correlations
with pathology. 
Key-words: Trypanosoma cruzi. Behavioral characterization. Genetic diversity.
Laboratório Multidisciplinar de Pesquisa em Doença de
Chagas, Faculdade de Ciências da Saúde, Universidade de
Brasília, Brasília, DF.
This work was supported by FINEP/CNPq, Brazil.
Address to: Drª Liana Lauria-Pires.Laboratório Multidisciplinar
de Pesquisa em Doença de Chagas/Faculdade de Ciências
da Saúde/UnB. CP: 04-536, 70919-970 Brasília, DF..
Fax: (061) 273-4645.
Recebido para publicação em 27/05/96.
Revista da Sociedade Brasileira de Medicina Tropical
30(3):187-192, mai-jun, 1997.
Lauria-Pires L, Santana JM, Tavares FS, Teixeira ARL. Diversity of Trypanosoma cruzi stocks and clones
derived from Chagas’ disease patients: I- Behavioral characterization in vitro. Revista da Sociedade Brasileira
de Medicina Tropical 30:187-192, mai-jun, 1997.
188
experiment, no growth was observed in the
wells receiving an aliquot of medium in which
the parasite could not be seen microscopically.
Growth kinet ics ,  doubling t ime and
differentiation. The T. cruzi stocks and clones
were maintained in liver infusion tryptose
(LIT) medium6. The behavioral characterization
of the parasite consisted of growth kinetics,
doubling time and percent of differentiation.
For the growth kinetics studies, stocks and
clones of the parasite harvested from tissue
culture were transferred in triplicate to LIT
medium. After three passages with 5 day-
intervals, the exponential growth phase
parasites were used to begin the study. Each
initial inoculum of 1 x 106 cells was seeded in
fresh LIT medium and the parasite growth was
de te rmined every  o ther  day unt i l  l a te
stationary phase. Aliquots of the parasite
culture forms were counted in triplicate using
a Neubauer cell counting chamber and an
inverted microscope at 100X magnification.
Smears of the parasite forms were fixed in
methanol, stained by Giemsa’s method and
mounted on coverslip. The glass slides were
examined under the microscope at 1000X
magnification. The percent of epimastigotes
and trypomastigotes were estimated from 300
flagellates counted in each smear.
RESULTS
In this study, the method used for parasite
cloning ascertained that each subsequent
clonal line derived from a single trypomastigote.
The parasite stock hSLU239, isolated from a
heart disease patient, yielded clones h1 and
h2. In addition, the parasite stock mSLU142,
isolated from a megaesophagus patient,
yielded clones m1, m2, m3, and m4. 
Figure 1 shows the means and standard
deviation of the parasite growth for a period of
22 days. Figure 1A shows the growth kinetics
of the T. cruzi stock hSLU239 and of its clones
h1 and h2. The parental stock and clone h1
showed similar dividing profile with quick
proliferation, and reached high cell number
( @ 2-3 x 107/ml) after 8 days. In contrast, clone
h2 derived from same parental stock showed
slow proliferation and substantial fewer cells
(@ 2 x 106/ml) after 8 days of growth.
Figure 1B shows percent of parasi te
d i f f e ren t i a t ion  f rom ep imas t igo tes  to
trypomastigotes in the axenic medium. These
observations were carried out through 22 days
of parasite growth. The T. cruzi stock hSLU239
showed maximum percent differentiation of
circa of 3% at days 12 and 14, whereas clone
h1 reached 15% at day 18, and clone h2
reached 10% at day 20. 
Figure 2A shows the growth kinetics of the
T. cruzi stock mSLU142 and of its four clones.
The parental stock and clone m2 showed
moderate growth: stock mSLU142 reached
approximately 1 x 107 cell culture forms/ml
after 10 days in axenic culture, whereas clone
Figure 1 - A) Profiles of Trypanosoma cruzi growth in LIT
medium; B) Patterns of the parasite differentiation from
epimastigotes to trypomastigotes in the axenic culture:
Stock hSLU239 (     ) and its clones h1 (     ) and h2 (     ).
Each finding represents the means ± standard deviation in
triplicate countings of at least 300 parasites. 
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m2 reached @ 3 x 106 cells/ml at day 12. In
marked contrast, clones m3 and m4 multiplied
very quickly and reached approximatelly
7 x 107 cells/ml after 12 days of growth. Figure
2B shows that  mSLU142 had moderate
differentiation reaching a maximum of 5 to 6
per cent between days 14 to 20. Clones m2
and m4 showed the lowest differentiation (1%)
f rom days 12 to 16 ,  whereas c lone m3
epimastigotes differentiated to circa 15%
trypomastigotes, at day 16 in LIT medium.
The T. cruzi population doubling time (DT)
was indicated by the number of hours required
for two-fold increase of the parasite population.
Table 1 shows the DT observed for each
parasite stock and clone. Interestingly, the DT
of stock hSLU239 (65.4 ± 0.9h) was similar to
that of stock mSLU142 (65.6 ± 4.9h). The DT of
both T. cruzi stocks, however, dif fered
significantly from their clones. Clone h1 DT
reached 37.5 ± 0.9, which was much lower
than that of clone h2 that required 87.2 ± 4.3h.
The parasite clones derived from the parental
mSLU142 also showed marked divergence.
Clone m2 showed DT of 56.4 ± 3.6h, whereas
clones m3 and m4 showed 38.4 ± 1h. In marked
contrast, clone m1 showed DT of 124.8 ± 3.6h. 
Table 1 - Doubling time of Trypanosoma cruzi stocks and clones in
LIT medium at 28oC.
Stocks Doubling time Mean ± SD
and clones (hours)*
hSLU239 64.3, 65.4, 66.5 65.4 ± 0.9
h1 39.4, 42.5, 41.7 37.5 ± 0.9
h2 83.9, 92.3, 85.4 87.2 ± 4.3
mSLU142 72.4, 61.3, 63.1 65.6 ± 4.9
m1 128.9, 120.1, 125.4 124.8 ± 3.6
m2 58.3, 59.5, 51.4 56.4 ± 3.6
m3 37.4, 39.5, 38.5 38.6 ± 0.9
m4 36.7, 38.4, 39.5 38.2 ± 1.1
* The doubling time in h was indicated by the parasite growth in
LIT medium at the exponential growth phase. Cell countings were
made every 48h from triplicate culture tubes.
An attempt to correlate the T. cruzi growth
kinetics with the parasite population doubling
time is shown in Figure 3. It was observed that
clones h2 and m1 that had very long DT
showed slow growth. Furthermore, clones m3
and m4 that had very short DT presented very
Figure 2 - A) Profiles of Trypanosoma cruzi growth in LIT
medium; B) Patterns of the parasite differentiation from
epimastigotes to trypomastigotes in the axenic culture:
Stock mSLU142 (       ) and its clones m1 (       ), m2 (      ),
m3 (       ) and m4 (      ). Each finding represents the means
standard deviation in triplicate countings of 300 parasites. 
Figure 3 - Patterns of Trypanosoma cruzi growth kinetics
and population doubling time in axenic culture. Doubling
time is shown on the axis; vertical bars represent
maximum yield of cells. Notice that stock mSLU142 that
had moderate doubling time presented low growth,
whereas clones m3 and m4 that had short doubling time
showed very high growth yield.
high growth yields reaching high cell
countings after 10 days in culture (Figure 2).
However, clone h1 that had very short DT
presented moderate growth (Figure 1). In
addition, stock hSLU239 that had moderate DT
showed high growth kinetics similar to those
shown by clones m3 and m4. 
In br ief ,  DT in LIT medium al lowed
classification of the populations of T. cruzi
stocks and clones into three groups: I- long DT
(from 87.4 to 124h) composed of clones h2
and m1; II- moderate DT (from 56.4 to 65.6),
consisted of stocks hSLU239, mSLU142 and
clone m2; III- short DT (from 37.5 to 38.2h),
which comprised clones h1, m3 and m4.
DISCUSSION
A stable behavioral marker for each single
parasite population used to infect a singeneic
host has been sought in order to determine
whether the outcome of lesions in Chagas
disease may be related to Trypanosoma cruzi
superinfections. In this paper we describe
several parasite populations (h1, h2, m1-m4) in
two stocks derived from patients with chronic
Chagas disease, which showed different
k inet ics  of  growth,  doubl ing t ime and
differentiation in axenic culture. This study
suggests that a particular pattern of in vitro
behavior of a parental T. cruzi stock can not
necessarily be extrapolated to its clones. For
example, the growth kinetics of clone h2 were
much slower than those observed for the
parental hSLU239. Also, clones m3 and m4
demonstrated more rapid growth kinetics than
the parental mSLU142. However, clone m1
showed significantly slower growth than the
parental mSLU142. Moreover, the parasite
population doubling time varied from one
clone to another regardless of stock origin. In
this regard, clones h2 and m1 (group I)
showed the longest doubling time, in contrast
with clones h1, m3 and m4 (group III) that
showed from one-half to one-third of the
doubling time. A correlation between the
kinet ics of growth and the populat ion
doubling time was not seen in all cases. This
observation is hard to explain because the
factors associated with the regulation of T.
cruzi population growth in axenic culture are
basically unknown. Furthermore, variability
between stock and derivative clonal lines is
also found for the parasite differentiation in
culture. Clones h1 and h2 differentiated more
extensively than their parental stock hSLU239,
whereas clones m2 and m4 showed minimal
differentiation.
It has been postulated that a particular
feature of a T. cruzi population might be
corre la ted to the pathology of  Chagas
disease1 3 8 10 11. The behavioral characteristics
of the parasite stocks and derived clones reported
here, however, are in keeping with the idea
that each Chagas disease patient is infected
with several T. cruzi populations having broad
biological diversity8 22 24. Some behavioral
aspects of a particular parasite population may
change from time to time7 12 25. In addition, it
has been shown that selection of some T. cruzi
populations may take place in the intestine of
the insect-vector13. Sampling (xeno) with D.
maximus may not have isolated all the biological
types. In this respect, the parasite populations
described in this paper will be used in the future
to determine if the T. cruzi stocks and clones
maintained in vitro and in vivo can change
their phenotypic profiles. 
The results of this study highlight the
dificulty of understanding the role that parasite
variation plays in the highly variable pathogenesis
of disease.  In order to c i rcumvent this
dif f iculty, an attempt has been made to
determine stable isoenzyme and DNA marker
of these clones, such as polymorphisms of
DNA sequences encoding the glycolytic enzymes
piruvate kynase2, fructose bi-phosphate
aldolase19, glucose phosphate isomerase18 and
glyceraldehyde-3-phosphate dehydrogenase16
for each parasite population17. In conclusion,
we believe that additional behavioral and
molecular markers are required for further
characterization of the various T. cruzi clones
present in the parasite stocks derived from
Chagas disease patients.
RESUMO
Neste  es tudo,  foram obt idos  es toques  de
Trypanosoma cruzi de pacientes chagásicos com a
doença cardíaca ou com megaesôfago. O estoque
hSLU239 (doença cardíaca) forneceu os clones h1 e
h2, enquanto o estoque mSLU142 (megaesôfago)
forneceu os clones m1, m2, m3 e m4. A cinética de
crescimento do parasito, tempo de duplicação e
diferenciação em meio líquido axênico mostraram
ampla diversidade comportamental. Observou-se que
um padrão particular de comportamento de um
estoque parental podia não ser necessariamente
encontrado na linhagem subclonal subseqüente.
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Este estudo indica que i) cada paciente chagásico é
infectado com várias subpopulações de T. cruzi; ii)
linhagens clonais derivadas de cada estoque do
parasito podem ter características biológicas diferentes
do isolado original de paciente chagásico; e que iii)
marcadores comportamentais e/ou moleculares
adicionais são necessários para melhor caracterização
de estoques de T. cruzi e seus clones derivados de
pacientes  com doença de Chagas ,  a  f im de
identificar as possíveis correlações com a patologia.
P a l a v r a s - c h a v e s :  Trypanosoma  c ruz i .
Caracterização do comportamento. Diversidade
genética.
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